Discount Agreement for Clobazam (SUE) by DAK-Gesundheit
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobazam (ausschl. Dafo SUE), ATC N05BA09 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Monate)
Status
Active
Submission Deadline
913 days remaining
Contracting authority
Location
Hamburg, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-262578-2026
Source
DAK-Gesundheit is seeking partners for a non-exclusive discount agreement for the active ingredient Clobazam (SUE) from June 2026 to May 2028, with an option to extend. This allows all pharmaceutical companies to join under attractive conditions.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 262578-2026HTML
- TED PDF — 262578-2026PDF
- TED XML — 262578-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024